How are young people spending their leisure time? Findings from a formative research study in rural central India using a daily activity schedule, V-Can Project

Autor: Devyani Wanjari, Radhika Sharma, Abhishek Raut, Arjunkumar Jakasania, Bishan Swarup Garg

Publikováno v: Social Medicine, Vol 17, Iss 3 (2024)

Introduction. The younger population is disproportionately affected by NCDs, which are also rapidly affecting the poorer sections of the Indian population. Adolescents' unhealthy food intake and lack of physical activity are major contributors to the

Externí odkaz: https://doaj.org/article/bc4ea74fff734bbb85a89e0df3df3682

Varespladib Inhibits the Phospholipase A2 and Coagulopathic Activities of Venom Components from Hemotoxic Snakes

Autor: Julien Slagboom, Nicholas R. Casewell, Govert W. Somsen, Zhengjin Jiang, Freek J. Vonk, Yumei Zhao, Jeroen Kool, Laura-Oana Albulescu, Kristina B.M. Still, Chunfang Xie

Publikováno v: Biomedicines
Volume 8
Issue 6
Biomedicines, Vol 8, Iss 165, p 165 (2020)
Xie, C, Albulescu, L O, Still, K B M, Slagboom, J, Zhao, Y, Jiang, Z, Somsen, G W, Vonk, F J, Casewell, N R & Kool, J 2020, ' Varespladib inhibits the phospholipase A 2 and coagulopathic activities of venom components from hemotoxic snakes ', Biomedicines, vol. 8, no. 6, 165, pp. 1-17 . https://doi.org/10.3390/biomedicines8060165
Biomedicines, 8(6):165, 1-17. MDPI AG

Phospholipase A2 (PLA2) enzymes are important toxins found in many snake venoms, and they can exhibit a variety of toxic activities including causing hemolysis and/or anticoagulation. In this study, the inhibiting effects of the small molecule PLA2 i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f876f0f58598a5e95659ee4aa142fa52

Effects of Extended-Release Niacin on Quartile Lp-PLA 2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial.

Autor: Lyubarova R; 1 Division of Cardiology, Albany Medical Center, Albany Medical College, Albany, NY, USA., Albers JJ; 2 University of Washington, Northwest Lipid Metabolism, And Diabetes Research Laboratories, Seattle, WA, USA., Marcovina SM; 2 University of Washington, Northwest Lipid Metabolism, And Diabetes Research Laboratories, Seattle, WA, USA., Yao Y; 3 Axio Research LLC, Seattle, WA, USA., McBride R; 3 Axio Research LLC, Seattle, WA, USA., Topliceanu A; 4 Division of Cardiology, Albany Medical Center, Albany Medical College, Albany, NY, USA., Anderson T; 5 University of Calgary and Libin Cardiovascular Institute, Foothills Medical Centre, Calgary, Canada., Fleg JL; 6 National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Desvigne-Nickens P; 6 National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Kashyap ML; 7 VA Long Beach Healthcare System, Long Beach, CA, USA., McGovern ME; 8 Miami Beach, FL, USA., Boden WE; 9 New England Healthcare System, Boston, MA, USA.

Publikováno v: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2019 Nov; Vol. 24 (6), pp. 534-541. Date of Electronic Publication: 2019 May 26.